We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Share News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,747.00
Bid: 1,742.00
Ask: 1,744.00
Change: 5.00 (0.29%)
Spread: 2.00 (0.115%)
Open: 1,763.00
High: 1,763.00
Low: 1,735.00
Prev. Close: 1,742.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Johnson Matthey, BHP Billiton, Spectris

Mon, 13th Jun 2016 16:24

(ShareCast News) - Johnson Matthey's rating was downgraded to 'hold' from 'add' but its target price was raised to 3,138p by Numis after the company reported its full year results.The speciality chemicals and sustainable technologies group last Thursday reported a 5% decrease in full year pre-tax profit to £418.2m, beating forecasts of £415m. Efforts to cut costs and an exceptional impairment and restructuring charge of £141m hit profits.Net debt was reduced by £319.5m despite funding a special dividend of £304.5m.Revenue rose 7% to £10,7m, boosted by a strong performance at its emission control technologies (ECT) business and progress in new business and fine chemicals. It offset sales declines in other parts of the group including process technologies and precious metal products.The firm expects slightly higher earnings in the coming year, saying the regulatory push for cleaner vehicles would bolster demand although competition would be intense."Near term earnings per share growth looks unlikely to be scintillating, so the investment case needs to look more to the medium term drivers and the potential in Europe especially as Real World Driving Emission standards oblige original equipment manufacturers to use Johnson Matthey to develop far cleaner diesel vehicles," said Numis analyst Charles Pick."A major shift away from diesel vehicles in Europe would be costly, whilst automotive markets are cyclical and weak Chinese demand may remain a feature for some operations for some time to come.Pick added: "Our target price has been amended to 3138p (from 2995p) based on a suggested multiple of c.16x estimated calendar year 2017 diluted earnings per share of around 196.1p." BHP Billiton has been rated as 'outperform' with a target price of 1050p by Credit Suisse as it said the company's investment case still holds after the Samarco disaster."BHP Billiton's oil business is setting it apart from the sector peer group and the company recently outlined positive FY17 cost and volume guidance," Credit Suisse said.Samarco Mineração SA -- a joint venture between BHP Billiton and Vale SA -- was held accountable for a November 2015 dam burst in Brazil that left 19 people dead and the town of Bento Rodrigues destroyed."While a significant and upmost serious issue, we do not think Samarco has the potential to undermine our overall positive view of the shares at this stage," said Credit Suisse, noting it awaited release of the more detailed full investigation into the tragedy."In our view, the incremental implications of this report are probably limited for BHP Billiton (but not positive), and we await release of the more detailed full investigation."The brokerage said its modelling allowed for $1.0bn in cash outflows for BHP Billiton in coming years relating to Samarco over coming years, meaning this should cover $2bn in total expenses should the Samarco JV company not have sufficient cash available.It added that with the full investigation into the causes of the disaster still not completed and released, it might be a "little premature to think that Samarco should be restarting operations anytime soon."Credit Suisse added that BHP Billiton was well-funded."Under spot oil, iron ore and copper prices, and within the dividend and capital expenditure guidance, BHP Billiton should have $7bn-plus of free cashflow for the year to June-2017." Spectris was navigating tough market conditions, like many of its peers, but management had also been restructuring the business to capture long-term secular growth in the markets which its serves, analysts at ShoreCap said, leading them to initiate the shares at a 'buy'.Furthermore, although margins were at a low point, ShoreCap analysts Ben McSkelly and Robin Speakman, said they perceived a recovery back towards historic levels which would allow the specialist instrumentation and controls business to leverage a secular growth trend around the mid-single digit level through the cycle.The company's new 'final assembler model', by which it outsources nearly 90% of is manufacturing, together with strict capital allocation, should allow margins to return to historical levels, the broker argued.Valuation-wise the stock was also 'attractive', ShoreCap noted, offering investors "a strong (indeed inefficient, in our view) balance sheet", with a net cash position set to emerge over the next year or so.In turn, that meant Spectris had the financial muscle necessary to be active in M&A, with a small bolt-on and strategic deals likely, with management having indicated a stronger move into services, according to McSkelly and Speakman."We expect a stronger trading environment to emerge over the next year, noting that the enterprise value/earnngs before interest, taxes, depreciation and amortisation multiple for fical year 2017 falls to 9.0x with a 6.4% free cash flow yield funding a growing dividend stream."
More News
19 Apr 2024 09:26

LONDON BROKER RATINGS: Peel Hunt starts NatWest and Barclays at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
10 Apr 2024 08:41

Johnson Matthey and BP win deal for US sustainable aviation fuel plant

(Alliance News) - Johnson Matthey PLC and BP PLC on Wednesday said their technology offering has been selected for use in a sustainable aviation fuel plant being built in the US state of Louisiana.

Read more
10 Apr 2024 07:47

LONDON BRIEFING: Stocks called up ahead of US inflation data

(Alliance News) - Stocks in London are called to open higher, as investors shake off nerves ahead of a key US inflation reading.

Read more
9 Apr 2024 09:51

Berenberg hikes target price on Johnson Matthey

(Sharecast News) - Analysts at Berenberg raised their target price on diversified chemicals business Johnson Matthey from 1,650.0p to 1,800.0p on Tuesday but said the performance of its shares will likely depend on three factors.

Read more
9 Apr 2024 08:54

LONDON BROKER RATINGS: Barclays raises Halma to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
9 Apr 2024 07:39

LONDON BRIEFING: HSBC sells Argentinian arm for USD550 million

(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors nervously look ahead to US inflation data and the European Central Bank's latest interest rate decision.

Read more
25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
20 Mar 2024 16:54

LONDON MARKET CLOSE: FTSE 100 treads water while Kering weighs on CAC

(Alliance News) - London's FTSE 100 finished the day largely as it started it, enduring an uninspiring session on Wednesday, with the latest Federal Reserve decision about an hour away.

Read more
20 Mar 2024 16:53

London close: Stocks mixed ahead of Fed, BoE decisions

(Sharecast News) - London markets closed with a mixed but little-changed performance on Wednesday, as investors digested a larger-than-expected slowdown in UK inflation.

Read more
20 Mar 2024 11:49

LONDON MARKET MIDDAY: Pre-Fed rate nerves push FTSE 100 in red

(Alliance News) - The FTSE 100 was in the red on Wednesday at midday, as relief from cooling UK inflation was not enough to shake off nerves ahead of the latest US Federal Reserve interest rate decision.

Read more
20 Mar 2024 08:45

LONDON MARKET OPEN: UK inflation cooler than expected ahead of BoE

(Alliance News) - The FTSE 100 in London opened lower on Wednesday morning, with cooler-than-expected inflation doing little to shake off pre-US Federal rate nerves.

Read more
20 Mar 2024 08:32

Johnson Matthey sells medical device components arm for USD700 million

(Alliance News) - Johnson Matthey PLC on Wednesday said it has agreed to sell its Medical Device Components business to Montagu Private Equity LLP, with the proceeds to fund a share buyback.

Read more
20 Mar 2024 07:40

LONDON BRIEFING: UK inflation cools to 3.4% in February; Eyes on Fed

(Alliance News) - Stocks in London are expected to open slightly lower on Wednesday, as investors digest some cooler-than-expected inflation in the UK and look ahead to the latest US interest rate decision.

Read more
20 Mar 2024 07:08

Johnson Matthey sells medical parts unit for $700m

(Sharecast News) - Johnson Matthey is selling its medical device components business to Montagu Private Equity for $700m (£550m), the company said on Wednesday.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.